SenesTech Announces Director Change and Officer Compensation
Ticker: SNES · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1680378
| Field | Detail |
|---|---|
| Company | Senestech, Inc. (SNES) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, officer-compensation, governance
TL;DR
SenesTech board shake-up: Dr. Smith out, Dr. Miller in. Officer pay details also filed.
AI Summary
SenesTech, Inc. announced on January 8, 2025, the departure of director Dr. Robert L. Smith and the appointment of Dr. David E. Miller as a new director. The company also reported on compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and changes in compensatory arrangements can sometimes indicate internal challenges or strategic realignments that warrant closer investor scrutiny.
Key Players & Entities
- SenesTech, Inc. (company) — Registrant
- Dr. Robert L. Smith (person) — Departing Director
- Dr. David E. Miller (person) — Appointed Director
- January 8, 2025 (date) — Date of earliest event reported
FAQ
Who is the departing director and when did their departure become effective?
Dr. Robert L. Smith is the departing director, and the earliest event reported is January 8, 2025.
Who is the newly appointed director?
Dr. David E. Miller has been appointed as a new director.
What is the principal executive office address for SenesTech, Inc.?
The principal executive offices are located at 777 W. Pinnacle Peak Road, Suite B104, Phoenix, AZ 85027.
What is the SIC code for SenesTech, Inc.?
The Standard Industrial Classification code for SenesTech, Inc. is 2870 (AGRICULTURE CHEMICALS).
What other items are being reported in this 8-K filing?
This 8-K filing also covers the election of directors, appointment of certain officers, and compensatory arrangements of certain officers, in addition to the departure of directors.
Filing Stats: 618 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-01-10 16:18:14
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value SNES The Nasdaq Stock Market
Filing Documents
- snes-20250108.htm (8-K) — 28KB
- snes-20250110xexx991.htm (EX-99.1) — 10KB
- image_0a.jpg (GRAPHIC) — 10KB
- 0001628280-25-001140.txt ( ) — 179KB
- snes-20250108.xsd (EX-101.SCH) — 2KB
- snes-20250108_lab.xml (EX-101.LAB) — 22KB
- snes-20250108_pre.xml (EX-101.PRE) — 13KB
- snes-20250108_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibits 99.1 Press Release dated January 10, 2025 (furnished herewith) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 10, 2025 SENESTECH, INC. By: /s/ Thomas C. Chesterman Thomas C. Chesterman Executive Vice President, Chief Financial Officer, Treasurer and Secretary